ChemoMetec A/S (CPH:CHEMM)
Denmark · Delayed Price · Currency is DKK 542.00
+15.00 (2.85%)
Sep 5, 2025, 4:59 PM CET
ChemoMetec Market Cap
ChemoMetec has a market cap or net worth of 9.43 billion as of September 5, 2025. Its market cap has increased by 42.26% in one year.
Market Cap
9.43B
Enterprise Value
9.18B
Revenue
459.54M
Ranking
n/a
PE Ratio
55.76
Stock Price
542.00
Market Cap Chart
Since December 18, 2006, ChemoMetec's market cap has increased from 374.48M to 9.43B, an increase of 2,418.70%. That is a compound annual growth rate of 18.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 9.43B | 11.48% |
| Dec 30, 2024 | 8.46B | 25.31% |
| Dec 29, 2023 | 6.75B | -43.81% |
| Dec 30, 2022 | 12.02B | -17.11% |
| Dec 30, 2021 | 14.50B | 44.12% |
| Dec 30, 2020 | 10.06B | 211.46% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1,555.20B |
| Coloplast | 141.54B |
| Genmab | 107.73B |
| Demant | 53.00B |
| ALK-Abelló | 44.95B |
| H. Lundbeck | 39.55B |
| Zealand Pharma | 31.53B |
| Ambu A/S | 25.77B |